insights_auto
Pse është ulur NOTA 2,14%?
Zhytu më thellëchevron_right
NOTA:FRA
Novartis AG
137,00 €
arrow_downward
-2,14%(-3,00) 1D
20 nën, 10:00:00 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOTA...
Hap
137,00 €
I lartë
137,00 €
I ulët
137,00 €
Kapitalizimi i tregut
305,32 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Hap
137,00 €
I lartë
137,00 €
I ulët
137,00 €
Kapitalizimi i tregut
305,32 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
The Globe and Mail
·
4 orë më parë
Goldman Sachs Sticks to Its Sell Rating for Novartis (NVS)
Yahoo Finance
·
1 ditë më parë
Novartis CEO leans on surge of pipeline readouts to quell growth fears
marketscreener.com
·
1 ditë më parë
RBC: Hopes for Higher Novartis Midterm Sales Growth 'Unrealistic,' Share Reaction 'Overdone'
Reuters
·
2 ditë më parë
Novartis trims medium-term growth target, shares fall
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
SektoriHealth Care
Industria-
Uebsajtinovartis.com